University of Texas Southwestern Medical Center Overview

Trial Radar AI Insights

University of Texas Southwestern Medical Center

The University of Texas Southwestern Medical Center leads groundbreaking clinical research in the United States, driving innovations in cancer, cardiovascular, and neurological therapies that directly benefit trial participants through access to cutting-edge treatments and personalised care. As a premier academic medical centre, it fosters a patient-first environment, enrolling thousands in trials that advance evidence-based medicine and improve outcomes for diverse populations.

• Institution Profile: Founded 1943 · Dallas, Texas, United States · Public (part of University of Texas System) · utsouthwestern.edu
• Therapeutic Strengths: Cancer, cardiovascular disease, brain and neurodegenerative diseases
• Research standing: Nobel Prize in Physiology or Medicine (1985) to Michael S. Brown and Joseph L. Goldstein for cholesterol metabolism discoveries; Breakthrough Prize in Life Sciences (2023) and Albert Lasker Basic Medical Research Award (2025) to Zhijian 'James' Chen for innate immunity research
• Partnerships: Collaborations with Pfizer, Merck, and Genentech expand oncology and immunotherapy trials; alliances with Children's Health and Scottish Rite for Children enhance paediatric research access

Clinical Research Infrastructure

The University of Texas Southwestern Medical Center operates a robust clinical research ecosystem anchored in Dallas, integrating academic expertise with community healthcare to support over 200 active lead-sponsored trials. This network emphasises multidisciplinary collaboration, enabling seamless patient recruitment and data collection across phases from early-phase I to IV studies.

Key hospitals and medical centres include the flagship William P. Clements Jr. University Hospital, which hosts advanced interventional trials, alongside affiliates such as Parkland Memorial Hospital for high-volume public health research, Children's Medical Center for paediatric specialties, and the VA North Texas Health Care System for veteran-focused studies.

Specialty institutes and research facilities feature the Harold C. Simmons Comprehensive Cancer Center, a National Cancer Institute-designated hub for oncology trials, and the Institute for Exercise and Environmental Medicine, dedicated to cardiovascular and metabolic investigations.

Key Specialties and Therapeutic Focus

• Primary focus areas (prioritised by expertise and reputation):
  • Cancer: Targets breast, lung, and kidney cancers through immunotherapy and chemoprevention; employs small molecules, biologics, and radiation therapies; leading specialists include Hans Hammers (medical oncology, kidney cancer) and David Gerber (medical oncology, lung cancer); notable breakthrough includes CRISPR gene-editing advancements in Eric Olson's lab for muscular dystrophy-related cancers.
  • Cardiovascular disease: Addresses heart failure, hyperthermia, and blood pressure disorders with procedural and device-based interventions; modalities include polypills and transcranial direct current stimulation; Helen H. Hobbs excels in internal medicine and molecular genetics for lipid disorders.
  • Brain and neurodegenerative diseases: Focuses on multiple sclerosis, depression, PTSD, and aging with behavioural, drug (e.g., ketamine), and diagnostic test approaches; Zhijian 'James' Chen leads in molecular biology and immunology, contributing to cGAS enzyme discovery for immune responses; Eric N. Olson advances regenerative medicine for neurological conditions.
  • Metabolism and diabetes: Explores obesity, cachexia, and cachexia-cancer links via dietary supplements and other interventions; breakthroughs stem from orexin discovery by Masashi Yanagisawa for sleep-metabolism regulation.
  • Genetics and human development: Integrates gene therapies and observational studies; foundational work by Brown and Goldstein on LDL receptors spurred statin development, transforming cholesterol management.

University of Texas Southwestern Medical Center Clinical Trials Landscape

Trial StatisticsApply Below Filters

The University of Texas Southwestern Medical Center sponsors 218 active trials as lead, encompassing recruiting, not-yet-recruiting, and active-not-recruiting statuses, with 149 focused on recruitment to engage diverse participants. These efforts have enrolled a total of 175,696 individuals across 382 locations, primarily in the United States (372 sites), averaging 806 participants per trial and spanning child (38 trials), adult (205), and older adult (187) demographics. Interventional studies dominate (159 of 218), targeting conditions like multiple sclerosis (50,040 enrollees) and heart failure (9 trials), while observational trials (59) support real-world insights into depression and cancer.

Key Clinical Trial Updates

In the past month, 33 trials received updates, reflecting ongoing progress in oncology and neurology, including interim analyses from phase II immunotherapy studies that suggest improved response rates in lung cancer patients. Primary completion dates cluster in late 2025 for several phase III cardiovascular trials, with expected data readouts on heart failure interventions by mid-2026, potentially informing regulatory submissions to the FDA. Recent successes include breakthrough approvals for novel diagnostics in multiple sclerosis, enhancing early detection and trial eligibility.

Trial Innovation

The centre pioneers patient-centric designs, such as adaptive protocols in depression trials incorporating transcranial direct current stimulation for real-time efficacy adjustments, alongside decentralised elements in PTSD studies using remote monitoring via digital apps. Integration of real-world evidence from VA affiliates bolsters observational trials on aging and obesity, while combination product interventions in cancer cachexia leverage AI-driven data analytics for personalised dosing.

Clinical Trial Participation Guide

Leverage Trial Radar's participation assistant to simplify trial details, preview steps with What to Expect, and confirm eligibility using Check Eligibility for University of Texas Southwestern Medical Center studies. Explore the Contacts & Locations tab to access site-specific information and connect directly with study teams at Dallas facilities or affiliates.

Explore University of Texas Southwestern Medical Center clinical trials

See 50 of 294 studies.